L-Carnitine has been reported to have beneficial effects in the reduction of serum
triglycerides and increases high-density lipoprotein cholesterol in hemodialysis patients …

Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine
concentrations and lipid effects. Previous studies have reported conflicting results of …

It has been reported that cumulative carnitine losses through dialysis membranes may
worsen hyperlipidemia during long-term hemodialysis. However, carnitine supplementation …

Although carnitine levels and carnitine therapy have been extensively studied in dialysis
patients, the pathophysiology of L-carnitine is poorly understood. The usual therapeutic …

Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and
biochemical effects. Since carnitine deficiency has been reported in some patients …

Twenty-one patients (median 49 years; range 20–72 years) on chronic haemodialysis
(median: 54 months; range 16–154 months) were examined in a clinical controlled trial for …

Twenty-nine hemodialyzed patients with hypertriglyceridemia were given l-carnitine (20
mg/kg iv at the end of each dialysis) for 120 days and then placebo for the same duration in …

Plasma carnitine levels were studied in 14 uremic patients before, during, and after
hemodialysis. The predialysis plasma carnitine levels were normal but fell during dialysis …

Carnitine is a conditionally essential metabolite that plays a critical role in cell physiology.
Carnitine is necessary for fatty acid transport to sites of beta-oxidation in the mitochondria …

Serum free and esterified carnitine levels as well as lipids were investigated in patients
undergoing regular hemodialysis (HD) treatment before and during 12 weeks of treatment …